American Chemical Society 248th National Meeting & Exposition Aug. 10-14, 2014 San Francisco

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WASHINGTON, Aug. 5, 2014 — The link below opens a wide variety of strictly embargoed news and feature material based on scientific reports that are scheduled for presentation in San Francisco, Aug. 10-14, at the 248th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society. The meeting is one of the year’s largest and most newsworthy scientific conferences. There will be nearly 12,000 reports on new discoveries that span scientific disciplines, including innovations in medicine, health, energy, food and the environment. Thousands of scientists and others are expected to attend. By accessing this content, you agree to honor all embargoes.

http://web.1.c2.audiovideoweb.com/1c2web3536/ACS_SanFran_2014/SFreleases.html

Once the releases go live, they will appear on our national meeting press page www.acs.org/sanfran2014releases.

Press conferences will stream over the Internet on the ACSLive Ustream channel . Reporters covering from their home bases have full access with Q&A capability. The press conference schedule is among the embargoed content.

The ACS Press Center will be open 7:30 a.m. - 5 p.m. Pacific Time, Sunday, Aug. 10, through Wednesday, Aug. 13, in Room 113 in the Moscone Center, North Building.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 161,000 members, ACS is the world’s largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC